Differential gene expression in models of pituitary prolactin-producing tumoral cells

Guardado en:
Detalles Bibliográficos
Autor principal: Giacomini, D.
Otros Autores: Haedo, M., Gerez, J., Druker, J., Páez-Pereda, M., Labeur, M., Stalla, G.K, Arzt, E.
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2009
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 14901caa a22016577a 4500
001 PAPER-8832
003 AR-BaUEN
005 20230518203840.0
008 190411s2009 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-66749133395 
024 7 |2 cas  |a prolactin, 12585-34-1, 50647-00-2, 9002-62-4; BMP4 protein, human; Bone Morphogenetic Protein 4; Neoplasm Proteins; RSUME protein, human; Receptors, Dopamine D2; Transcription Factors 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a HRMRA 
100 1 |a Giacomini, D. 
245 1 0 |a Differential gene expression in models of pituitary prolactin-producing tumoral cells 
260 |c 2009 
270 1 0 |m Giacomini, D.; Laboratorio de Fisiología y Biología Molecular, Departamento de Fisiología, Biología Molecular y Celular, Universidad de Buenos Aires, Buenos Aires, Argentina 
506 |2 openaire  |e Política editorial 
504 |a Asa, S.L., Ezzat, S., The cytogenesis and pathogenesis of pituitary adenomas (1998) Endocr Rev, 19, pp. 798-827 
504 |a Ezzat, S., Asa, S.L., Mechanisms of disease: The pathogenesis of pituitary tumors (2006) Nat Clin Pract Endocrinol Metab, 2, pp. 220-230 
504 |a Arzt, E., Pereda, M.P., Castro, C.P., Pagotto, U., Renner, U., Stalla, G.K., Pathophysiological role of the cytokine network in the anterior pituitary gland (1999) Front Neuroendocrinol, 20, pp. 71-95 
504 |a Arzt, E., gp130 cytokine signaling in the pituitary gland: A paradigm for cytokine-neuroendocrine pathways (2001) J Clin Invest, 108, pp. 1729-1733 
504 |a Clayton, R.N., Farrell, W.E., Pituitary tumour clonality revisited (2004) Front Horm Res, 32, pp. 186-204 
504 |a Alexander, J.M., Biller, B.M., Bikkal, H., Zervas, N.T., Arnold, A., Klibanski, A., Clinically nonfunctioning pituitary tumors are monoclonal in origin (1990) J Clin Invest, 86, pp. 336-340 
504 |a Kovacs, K., Horvath, E., Vidal, S., Classification of pituitary adenomas (2001) J Neurooncol, 54, pp. 121-127 
504 |a Yu, R., Melmed, S., Oncogene activation in pituitary tumors (2001) Brain Path, 11, pp. 328-341 
504 |a Melmed, S., Update in pituitary disease (2008) J Clin Endocrinol Metab, 93, pp. 331-338 
504 |a Castro, C.P., Giacomini, D., Nagashima, A.C., Onofri, C., Graciarena, M., Kobayashi, K., Paez-Pereda, M., Arzt, E., Reduced expression of the cytokine transducer gp130 inhibits hormone secretion, cell growth, and tumor development of pituitary lactosomatotrophic GH3 cells (2003) Endocrinology, 144, pp. 693-700 
504 |a Carbia-Nagashima, A., Gerez, J., Perez-Castro, C., Paez-Pereda, M., Silberstein, S., Stalla, G.K., Holsboer, F., Arzt, E., RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-lalpha during hypoxia (2007) Cell, 131, pp. 309-323 
504 |a Renner, U., Lohrer, P., Schaaf, L., Feirer, M., Schmitt, K., Onofri, C., Arzt, E., Stalla, G.K., Transforming growth factor-beta stimulates vascular endothelial growth factor production by folliculostellate pituitary cells (2002) Endocrinology, 143, pp. 3759-3765 
504 |a Gloddek, J., Pagotto, U., Paez Pereda, M., Arzt, E., Stalla, G.K., Renner, U., Pituitary adenylate cy-clase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells (1999) J Endocrinol, 160, pp. 483-490 
504 |a Onofri, C., Theodoropoulou, M., Losa, M., Uhl, E., Lange, M., Arzt, E., Stalla, G.K., Renner, U., Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: Detection of a non-en-dothelial function of VEGF in pituitary tumours (2006) J Endocrinol, 191, pp. 249-261 
504 |a Paez-Pereda, M., Giacomini, D., Refojo, D., Nagashima, A.C., Hopfner, U., Grubler, Y., Chervin, A., Arzt, E., Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk (2003) Proc Natl Acad Sci USA, 100, pp. 1034-1039 
504 |a Schmierer, B., Hill, C.S., TGFbeta-SMAD signal transduction: Molecular specificity and functional flexibility (2007) Nat Rev Mol Cell Biol, 8, pp. 970-982 
504 |a Massague, J., TGF-beta signal transduction (1998) Annu Rev Biochem, 67, pp. 753-791 
504 |a Massague, J., How cells read TGF-beta signals (2000) Nat Rev Mol Cell Biol, 1, pp. 169-178 
504 |a Hentges, S., Sarkar, D.K., Transforming growth factor-beta regulation of estradiol-induced prolactinomas (2001) Front Neuroendocrinol, 22, pp. 340-363 
504 |a Shi, Y., Massague, J., Mechanisms of TGF-beta signalingfrom cell membrane to the nucleus (2003) Cell, 113, pp. 685-700 
504 |a Massague, J., Chen, Y.G., Controlling TGF-beta signaling (2000) Genes Dev, 14, pp. 627-644 
504 |a Bellusci, S., Henderson, R., Winnier, G., Oikawa, T., Hogan, B.L., Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis (1996) Development, 122, pp. 1693-1702 
504 |a Hogan, B.L., Blessing, M., Winnier, G.E., Suzuki, N., Jones, C.M., Growth factors in development: The role of TGF-beta related polypeptide signalling molecules in embryogenesis (1994) Dev Suppl, pp. 53-60 
504 |a Winnier, G., Blessing, M., Labosky, P.A., Hogan, B.L., Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse (1995) Genes Dev, 9, pp. 2105-2116 
504 |a Wilson, P.A., Hemmati-Brivanlou, A., Induction of epidermis and inhibition of neural fate by Bmp-4 (1995) Nature, 376, pp. 331-333 
504 |a Harland, R.M., Neural induction in Xenopus (1994) Curr Opin Genet Dev, 4, pp. 543-549 
504 |a Sasai, Y., Lu, B., Steinbeisser, H., De Robertis, E.M., Regulation of neural induction by the Chd and Bmp-4 antagonistic patterning signals in Xenopus (1995) Nature, 377, p. 757 
504 |a Lamb, T.M., Knecht, A.K., Smith, W.C., Stachel, S.E., Economides, A.N., Stahl, N., Yancopolous, G.D., Harland, R.M., Neural induction by the secreted polypeptide noggin (1993) Science, 262, pp. 713-718 
504 |a Rossi, J.M., Dunn, N.R., Hogan, B.L., Zaret, K.S., Distinct mesodermal signals, including BMPs from septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm (2001) Genes Dev, 15, pp. 1998-2009 
504 |a Dudley, A.T., Lyons, K.M., Robertson, E.J., A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye (1995) Genes Dev, 9, pp. 2795-2807 
504 |a Roberts, D.J., Johnson, R.L., Burke, A.C., Nelson, C.E., Morgan, B.A., Tabin, C., Sonic hedgehog is an endodermal signal inducing Bmp-4 and Hox genes during induction and regional-ization of the chick hindgut (1995) Development, 121, pp. 3163-3174 
504 |a Giacomini, D., Paez-Pereda, M., Theodoropoulou, M., Gerez, J., Nagashima, A.C., Chervin, A., Berner, S., Arzt, E., Bone morphogenetic pro-tein-4 control of pituitary pathophysiology (2006) Front Horm Res, 35, pp. 22-31 
504 |a Takeda, M., Otsuka, F., Suzuki, J., Kishida, M., Ogura, T., Tamiya, T., Makino, H., Involvement of activin/BMP system in development of human pituitary gonadotropinomas and nonfunctioning adenomas (2003) Biochem Biophys Res Commun, 306, pp. 812-818 
504 |a Kawabata, M., Imamura, T., Miyazono, K., Signal transduction by bone morphogenetic proteins (1998) Cytokine Growth Factor Rev, 9, pp. 49-61 
504 |a Chen, C.R., Kang, Y., Massague, J., Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program (2001) Proc Natl Acad Sci USA, 98, pp. 992-999 
504 |a Yagi, K., Furuhashi, M., Aoki, H., Goto, D., Kuwano, H., Sugamura, K., Miyazono, K., Kato, M., c-myc is a downstream target of the Smad pathway (2002) J Biol Chem, 277, pp. 854-861 
504 |a Nudi, M., Ouimette, J.F., Drouin, J., Bone mor-phogenic protein (Smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx/Tpit activity (2005) Mol Endocrinol, 19, pp. 1329-1342 
504 |a Morris, D., Grossman, A., The medical management of Cushing's syndrome (2002) Ann NY Acad Sci, 970, pp. 119-133 
504 |a Nieman, L.K., Medical therapy of Cushing's disease (2002) Pituitary, 5, pp. 77-82 
504 |a De Herder, W.W., Lamberts, S.W., Octapeptide somatostatin-analogue therapy of Cushing's syndrome (1999) Postgrad Med J, 75, pp. 65-66 
504 |a Boscaro, M., Barzon, L., Fallo, F., Sonino, N., Cushing's syndrome (2001) Lancet, 357, pp. 783-791 
504 |a Merino, R., Hurle, J.M., The molecular basis of retinoid action in tumors (2003) Trends Mol Med, 9, pp. 509-511 
504 |a Lotan, R., Retinoids in cancer chemopreven-tion (1996) Faseb J, 10, pp. 1031-1039 
504 |a Kurie, J.M., The biologic basis for the use of retinoids in cancer prevention and treatment (1999) Curr Opin Oncol, 11, pp. 497-502 
504 |a Kurie, J.M., Hong, W.K., Retinoids as antitumor agents: A new age of biological therapy (1999) Cancer J Sci Am, 5, pp. 150-151 
504 |a Kang, H.J., Song, M.R., Lee, S.K., Shin, E.C., Choi, Y.H., Kim, S.J., Lee, J.W., Lee, M.O., Retinoic acid and its receptors repress the expression and transactivation functions of Nur77: A possible mechanism for the inhibition of apoptosis by retinoic acid (2000) Exp Cell Res, 256, pp. 545-554 
504 |a Fanjul, A., Dawson, M.I., Hobbs, P.D., Jong, L., Cameron, J.F., Harlev, E., Graupner, G., Pfahl, M., A new class of retinoids with selective inhibition of AP-1 inhibits proliferation (1994) Nature, 372, pp. 107-111 
504 |a Philips, A., Lesage, S., Gingras, R., Maira, M.H., Gauthier, Y., Hugo, P., Drouin, J., Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells (1997) Mol Cell Biol, 17, pp. 5946-5951 
504 |a Maira, M., Martens, C., Philips, A., Drouin, J., Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation (1999) Mol Cell Biol, 19, pp. 7549-7557 
504 |a Kovalovsky, D., Refojo, D., Liberman, A.C., Hochbaum, D., Pereda, M.P., Coso, O.A., Stalla, G.K., Arzt, E., Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: Involvement of calcium, protein kinase A, and MAPK pathways (2002) Mol Endocrinol, 16, pp. 1638-1651 
504 |a Páez-Pereda, M., Kovalovsky, D., Hopfner, U., Theodoropoulou, M., Pagotto, U., Uhl, E., Losa, M., Stalla, G., Retinoic acid prevents experimental Cushing syndrome (2001) J Clin Invest, 108, pp. 1123-1131 
504 |a Ling, G.V., Stabenfeldt, G.H., Comer, K.M., Cribble, D.H., Schechter, R.D., Canine hyperadreno-corticism: Pretreatment clinical and laboratory evaluation of 117 cases (1979) J Am Vet Med Assoc, 174, pp. 1211-1215 
504 |a Castillo, V., Giacomini, D., Paez-Pereda, M., Stalla, J., Labeur, M., Theodoropoulou, M., Holsboer, F., Arzt, E., Retinoic acid as a novel medical therapy for Cushing's disease in dogs (2006) Endocrinology, 147, pp. 4438-4444 
504 |a Giacomini, D., Paez-Pereda, M., Theodoropoulou, M., Labeur, M., Refojo, D., Gerez, J., Chervin, A., Arzt, E., Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action (2006) Endocrinology, 147, pp. 247-256 
504 |a Yamamoto, T., Saatcioglu, F., Matsuda, T., Crosstalk between bone morphogenic proteins and estrogen receptor signaling (2002) Endocrinology, 143, pp. 2635-2642 
504 |a Matsuda, T., Yamamoto, T., Muraguchi, A., Saatcioglu, F., Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3 (2001) J Biol Chem, 276, pp. 42908-42914 
593 |a Laboratorio de Fisiología y Biología Molecular, Departamento de Fisiología, Biología Molecular y Celular, Universidad de Buenos Aires, Buenos Aires, Argentina 
593 |a Max-Planck Institute of Psychiatry, Munich, Germany 
593 |a Affectis Pharmaceuticals, Munich, Germany 
593 |a IFYBINE-Argentine National Research Council (CONICET), Argentina 
593 |a Lab. Fisiología y Biología Molecular, Departamento de Fisiología, Biología Molecular y Celular FCEN, Pabellon II, AR-1428 Buenos Aires, Argentina 
690 1 0 |a BMP-4 
690 1 0 |a CUSHING'S DISEASE 
690 1 0 |a OESTROGENS 
690 1 0 |a PROLACTINOMAS 
690 1 0 |a RSUME 
690 1 0 |a TGF-Β 
690 1 0 |a BONE MORPHOGENETIC PROTEIN 4 
690 1 0 |a DOPAMINE 2 RECEPTOR 
690 1 0 |a MESSENGER RNA 
690 1 0 |a PROLACTIN 
690 1 0 |a TRANSFORMING GROWTH FACTOR BETA 
690 1 0 |a BMP 4 GENE 
690 1 0 |a CARCINOGENESIS 
690 1 0 |a CELL LINE 
690 1 0 |a CELL LINEAGE 
690 1 0 |a CONFERENCE PAPER 
690 1 0 |a GENE EXPRESSION 
690 1 0 |a GENE IDENTIFICATION 
690 1 0 |a HORMONE SYNTHESIS 
690 1 0 |a HUMAN 
690 1 0 |a HYPOPHYSIS 
690 1 0 |a HYPOPHYSIS TUMOR 
690 1 0 |a IN VIVO STUDY 
690 1 0 |a NONHUMAN 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a PROLACTINOMA 
690 1 0 |a PROTEIN FUNCTION 
690 1 0 |a RSUME GENE 
690 1 0 |a SIGNAL TRANSDUCTION 
690 1 0 |a TUMOR CELL 
690 1 0 |a VASCULARIZATION 
690 1 0 |a ANIMALS 
690 1 0 |a BONE MORPHOGENETIC PROTEIN 4 
690 1 0 |a CELL HYPOXIA 
690 1 0 |a CELL LINE, TUMOR 
690 1 0 |a CELL TRANSFORMATION, NEOPLASTIC 
690 1 0 |a GENE EXPRESSION PROFILING 
690 1 0 |a GENE EXPRESSION REGULATION, NEOPLASTIC 
690 1 0 |a HUMANS 
690 1 0 |a MICE 
690 1 0 |a MICE, KNOCKOUT 
690 1 0 |a MODELS, BIOLOGICAL 
690 1 0 |a NEOPLASM PROTEINS 
690 1 0 |a PROLACTINOMA 
690 1 0 |a RECEPTORS, DOPAMINE D2 
690 1 0 |a SIGNAL TRANSDUCTION 
690 1 0 |a TRANSCRIPTION FACTORS 
700 1 |a Haedo, M. 
700 1 |a Gerez, J. 
700 1 |a Druker, J. 
700 1 |a Páez-Pereda, M. 
700 1 |a Labeur, M. 
700 1 |a Stalla, G.K. 
700 1 |a Arzt, E. 
773 0 |d 2009  |g v. 71  |h pp. 88-94  |k n. SUPPL2  |p Horm. Res.  |x 03010163  |w (AR-BaUEN)CENRE-4908  |t Hormone Research 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-66749133395&doi=10.1159%2f000192444&partnerID=40&md5=d6dd0e382789f786318dab5ac2e05d86  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1159/000192444  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_03010163_v71_nSUPPL2_p88_Giacomini  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03010163_v71_nSUPPL2_p88_Giacomini  |y Registro en la Biblioteca Digital 
961 |a paper_03010163_v71_nSUPPL2_p88_Giacomini  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 69785